查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1992183

支气管镜切片检查器械市场：按技术、产品类型、手术类型、应用和最终用户划分－2026-2032年全球市场预测

Bronchoscopic Biopsy Devices Market by Technology, Product Type, Procedure Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，支气管镜切片检查设备市场价值将达到 8.2215 亿美元，到 2026 年将成长至 8.8488 亿美元，到 2032 年将达到 14.1304 亿美元，年复合成长率为 8.04%。

主要市场统计数据
基准年 2025 8.2215亿美元
预计年份：2026年 8.8488亿美元
预测年份 2032 141304亿美元
复合年增长率 (%) 8.04%

本节提供清晰且基于临床的介绍，概述了支气管镜切片检查装置的发展历程、其临床证据以及影响其在临床实践中实施的操作因素。

支气管切片检查设备融合了呼吸内科、肿瘤科和介入内视镜技术，使临床医生能够更精准地获取胸腔病变，同时最大限度地减少患者併发症。近年来，影像、导航和设备小型化技术的进步拓展了诊断范围，使其涵盖肺部週边区域并优化了纵隔评估。这催生了新的临床工作流程，并促进了呼吸科医生、胸腔外科医生和介入放射科医生之间的跨学科合作。在此背景下，从设备製造商到医院采购团队等相关人员都需要清晰且基于临床的视角，了解不断发展的技术趋势、操作流程以及推动技术应用的关键因素，从而指南策略规划。

本文简要概述了由导航、分散式和整合式临床工作流程驱动的、正在重塑支气管镜切片检查设备格局的关键变革性变化。

由于技术融合、操作流程分散化以及临床对微创诊断途径日益增长的需求，支气管镜切片检查器械领域正经历变革性的转变。将即时成像与电磁或虚拟引导结合的导航技术，已将支气管镜平台的触及范围扩展至以往只能透过经胸途径到达的肺週组织。同时，内视镜光学系统、器械通道设计和切片检查器械的改进，提高了诊断准确性并降低了併发症率。因此，临床医师信心倍增，多专业肿瘤会诊中的转诊模式也正在改变。

分析 2025 年美国实施的累积关税对支气管镜切片检查设备的供应链、价格趋势和采购方式的连锁反应。

关税调整和贸易政策措施将对医疗设备（包括支气管镜切片检查平台和耗材）供应链的经济效益、定价策略和采购决策产生重大影响。 2025年，美国实施的累积关税调整对某些类别的医疗设备进口加征了额外关税，迫使製造商和经销商重新评估其筹资策略和服务交付成本模式。对于依赖跨境零件采购的公司而言，这些措施促使它们更加重视近岸外包、供应商整合以及重新谈判贸易条款，以维持利润率并与主要客户保持价格竞争力。

从细緻入微、基于细分的观点，揭示技术、产品架构、临床应用、最终用户画像和流程目标如何影响采用和价值获取。

細項分析揭示了支气管切片检查设备在应用路径和价值创造需求方面的差异，这些差异体现在核心技术、产品类型、应用、最终用户和手术类型等多个维度上。在技​​术层面，临床计画对凸阵探头EBUS、电磁导航和径向EBUS平台在影像解析度、导航精度和手术效率方面的优劣进行了评估，每种模式都适用于不同的应用情境和操作者的专业程度。基于产品类型，设备的选择受手术复杂性和医疗机构的处理能力的影响。单通道设备因其简化诊断流程而更受青睐，而双通道设备则因其治疗的多样性而备受青睐。超细设备能够到达远端週边病变，而这些病变通常需要经皮才能到达。

区域洞察框架，比较美洲、欧洲、中东和非洲以及亚太地区的临床实施模式、法规环境和商业性实施重点。

区域趋势正在影响美洲、欧洲、中东和非洲以及亚太地区的临床实践模式、监管路径和商业性策略，为支气管镜切片检查器械领域的相关人员带来不同的机会和实施风险。在美洲，成熟的介入呼吸系统计画和综合癌症中心支持早期采用先进的导航技术以及诊断和治疗相结合的程序。同时，私人保险公司模式和大规模医院网路则促使人们更加关注可验证的手术效率和全面的诊疗路径。该地区的采购週期往往重视临床疗效的比较证据、报销相容性以及完善的上市后监测。

这份竞争情报概述重点介绍了成熟企业、专家创新者和策略伙伴关係关係如何塑造产品差异化、临床检验和商业化。

支气管镜切片检查设备市场的竞争动态是由传统内视镜製造商、专业导航设备供应商以及雄心勃勃的医疗技术Start-Ups共同推动的，这些新创公司致力于在成像、软体和耗材设计方面进行创新。成熟企业通常利用其已建立的临床关係、全球服务网络和丰富的产品系列，提供能够提高手术效率和提供全生命週期支援的整合解决方案。新参与企业和细分市场参与者则倾向于透过提供特定的效能优势来展开竞争，例如更远的外周照射距离、更简化的使用者介面或低成本的一次性耗材，这些优势有可能在特定专案中取代传统的操作流程。

为销售、临床和价值链领导者提供切实可行的策略建议，以加速产品推广、确保基于价值的合约并降低业务风险。

产业领导者必须采取平衡的策略，将临床证据的累积、供应链的韧性以及与相关人员利益相符的商业模式相结合，以确保支气管镜切片检查设备的持续应用。首先，应优先进行前瞻性临床试验和真实世界证据（REW）研究，以证明其在纵隔分期和周边病变取样等关键适应症中具有相对较高的安全性和诊断性能。与相关人员利益相符的报销证据将有助于在预算紧张的环境下加速设备的应用。其次，应透过供应商多元化、区域组装方案和库存优化来提高供应链的柔软性，同时降低关税和地缘政治风险，并保持价格竞争力以及快速的服务反应。

透过采用高度透明的调查方法，结合与临床医生的访谈、与供应商的咨询、文献综述和供应链映射，我们能够从多个角度检验见解，并证明其实际适用性。

本分析的调查方法结合了与临床和商业相关人员的直接对话、对监管和临床文献的系统性回顾以及定性供应链分析，以确保对支气管镜切片检查器械生态系统的全面了解。关键资讯来源包括对介入性肺科医生、胸腔外科医生、医院采购经理和医疗设备工程专家的深入访谈，这些访谈揭示了实际的手术流程、器械偏好和培训需求。除上述对话外，还与器械开发商和销售合作伙伴进行了磋商，以了解产品蓝图、商业化挑战和生产方面的考虑。

简洁扼要的结论整合了临床创新、营运韧性和实证商业化如何共同作用，从而决定支气管镜切片检查设备的长期价值创造。

简而言之，支气管切片检查设备正朝着提高临床准确性、分散式操作流程和数据驱动的整合式工作流程方向发展，所有这些都在扩大其在现代胸腔外科医学中的作用。导航精度、超薄设备和多通道多功能性等技术差异将继续决定其在中心、纵隔和周边适应症的临床适用性。同时，商业性成功将取决于可靠的临床证据、能够抵御关税和贸易波动的灵活供应链，以及能够反映从门诊诊所到大规模医院系统等终端用户多样化经济状况的经营模式。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 支气管镜切片检查设备市场：依技术分类

  • 凸阵探头 EBUS
  • 电磁导航
  • 径向 EBUS

第九章 支气管镜切片检查设备市场：依产品类型划分

  • 双通道设备
  • 单通道元件
  • 超薄设备

第十章 支气管镜切片检查设备市场（依手术类型划分）

  • 诊断性切片检查
  • 治疗性介入

第十一章 支气管镜切片检查设备市场：按应用领域划分

  • 中央病变的诊断
  • 纵膈分期
    • 常规经支气管针吸切片术
    • EBUS引导下经支气管针吸切片手术
  • 週边性病变的诊断
    • 无需导航的直接切片检查
    • 电磁感应切片检查
    • 虚拟支气管镜导航

第十二章 支气管镜切片检查设备市场：依最终用户划分

  • 门诊手术中心
    • 公司所有权
    • 医生所有
  • 医院手术室
    • 私立医院
    • 公立医院
  • 专科癌症中心

第十三章 支气管镜切片检查器械市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 支气管镜切片检查器械市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 支气管镜切片检查器械市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国支气管镜切片检查设备市场

第十七章：中国支气管镜切片检查器械市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ambu A/S
  • Becton, Dickinson, and Company
  • Body Vision Medical Inc.
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group Incorporated
  • Erbe Elektromedizin GmbH
  • FUJIFILM Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Medi-Globe GmbH
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Micro-Tech（Nanjing）Co., Ltd
  • Olympus Corporation
  • Richard Wolf GmbH
  • Shanghai Aohua Photoelectricity Endoscope Co.,Ltd.
  • Teleflex Incorporated
Product Code: MRR-C92ADB4B7664

The Bronchoscopic Biopsy Devices Market was valued at USD 822.15 million in 2025 and is projected to grow to USD 884.88 million in 2026, with a CAGR of 8.04%, reaching USD 1,413.04 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 822.15 million
Estimated Year [2026] USD 884.88 million
Forecast Year [2032] USD 1,413.04 million
CAGR (%) 8.04%

A clear and clinically grounded introduction that frames bronchoscopic biopsy device evolution, clinical rationale, and the operational drivers that shape adoption across healthcare settings

Bronchoscopic biopsy devices sit at the intersection of pulmonology, oncology, and interventional endoscopy, enabling clinicians to access thoracic lesions with increasing precision while minimizing patient morbidity. Recent advances in imaging, navigation, and device miniaturization have expanded diagnostic reach into peripheral lung territories and optimized mediastinal evaluation, creating new clinical workflows and cross-disciplinary collaboration between pulmonologists, thoracic surgeons, and interventional radiologists. Against this backdrop, stakeholders from device manufacturers to hospital procurement teams require a clear, clinically grounded synthesis of the evolving technology landscape, procedural pathways, and adoption enablers to inform strategy.

This introduction synthesizes the clinical rationale for bronchoscopic biopsy, highlights key device classes and their functional distinctions, and outlines the principal adoption drivers in contemporary practice. It also frames how reimbursement dynamics, procedure setting diversification, and clinician training intersect with technological evolution to shape deployment. By setting this context, readers will be positioned to understand downstream analyses of market forces, regulatory impacts, segmentation nuances, and recommended strategic responses that follow in the report.

A concise synthesis of the key transformative shifts reshaping the bronchoscopic biopsy device landscape driven by navigation, decentralization, and integrated clinical workflows

The landscape for bronchoscopic biopsy devices is undergoing transformative shifts driven by technological convergence, procedural decentralization, and heightened clinical demand for less invasive diagnostic pathways. Navigation technologies that integrate real-time imaging with electromagnetic or virtual guidance have extended the reach of bronchoscopic platforms into peripheral lung tissue previously accessible primarily by transthoracic approaches. Concurrent improvements in endoscope optics, tool channel engineering, and sampling instruments have improved diagnostic yield and reduced complication rates, which in turn have led to broader clinician confidence and evolving referral patterns within multidisciplinary tumor boards.

At the same time, the procedural setting is diversifying: ambulatory procedural centers and specialized cancer units are emerging as viable venues for selected bronchoscopic procedures, supported by streamlined sedation protocols and shorter recovery workflows. This shift is accompanied by growing interest in combined diagnostic and therapeutic pathways that pair biopsy with localized interventions or molecular sampling to inform precision oncology. Additionally, data and software are becoming central components of the value proposition; integration of navigation outputs with electronic health records and pathology workflows enhances longitudinal care coordination and supports value-based contracting. Taken together, these shifts are creating new imperatives for device makers, health systems, and clinical leaders to reassess product portfolios, training programs, and partnerships in order to capture evolving clinical pathways and institutional priorities.

An analysis of how the cumulative United States tariffs enacted in 2025 reverberated through supply chains, pricing dynamics, and procurement approaches for bronchoscopic biopsy devices

Tariff changes and trade policy actions can exert a material influence on the supply chain economics, pricing strategies, and procurement decisions for medical devices, including bronchoscopic biopsy platforms and consumables. In 2025, cumulative tariff adjustments enacted by the United States imposed added duties on select categories of medical device imports, prompting manufacturers and distributors to re-evaluate sourcing strategies and cost-to-serve models. For companies relying on cross-border component supply, these measures intensified focus on nearshoring, supplier consolidation, and renegotiation of commercial terms to maintain margin and competitive pricing in key accounts.

Operationally, healthcare providers experienced heightened procurement diligence as hospital purchasing teams and group purchasing organizations examined total landed costs, incorporating tariff-related price movements into capital planning and consumables budgeting. In response, several suppliers accelerated localization of assembly, increased inventory buffers at domestic distribution hubs, and introduced modular product configurations to reduce dependence on tariff-exposed subassemblies. From a strategic perspective, the tariffs catalyzed contractual innovations including longer-term price agreements, value-sharing models tied to outcomes, and expanded service offerings to preserve adoption momentum amid tighter budgetary constraints. Looking ahead, the cumulative effect of these measures underscores the need for manufacturers and health systems to maintain flexible supply networks, scenario-based pricing strategies, and transparent cost communication that align with institutional procurement policies and clinical imperatives.

A granular segmentation-driven perspective that clarifies how technology, product architecture, clinical application, end-user profiles, and procedure objectives shape adoption and value capture

Segmentation analysis reveals differentiated adoption pathways and value imperatives across the core technology, product, application, end user, and procedure type dimensions of bronchoscopic biopsy devices. Based on technology, clinical programs evaluate trade-offs among convex probe EBUS, electromagnetic navigation, and radial EBUS platforms in terms of imaging fidelity, navigation accuracy, and procedural ergonomics, with each modality aligning to distinct diagnostic use cases and operator expertise. Based on product type, device selection is influenced by procedural complexity and institutional throughput, with single channel devices preferred for streamlined diagnostic workflows, double channel devices valued for therapeutic versatility, and ultrathin devices enabling access to distal peripheral lesions that would otherwise require percutaneous approaches.

Based on application, clinical protocols and purchasing choices reflect the needs of central lesion diagnosis, mediastinal staging, and peripheral lesion diagnosis; within mediastinal staging clinicians further differentiate between conventional TBNA and EBUS-guided TBNA for procedural accuracy and sampling yield, while peripheral lesion diagnosis pathways bifurcate into direct sampling without navigation, electromagnetic navigated sampling, and virtual bronchoscopy navigation based on lesion location and institutional imaging capabilities. Based on end user, adoption dynamics are shaped by the operational profile of ambulatory surgical centers, hospital operating rooms, and specialized cancer centers, with ambulatory surgical centers further segmented into corporate owned and physician owned models, and hospital operating rooms divided between private and public hospital systems that have distinct procurement cycles, credentialing practices, and throughput expectations. Based on procedure type, device configurations and service bundles are tailored to whether the primary objective is diagnostic biopsy or therapeutic intervention, influencing consumable design, sterilization workflows, and perioperative support. By synthesizing these segmentation lenses, stakeholders can prioritize product development, training, and commercial strategies that are tightly aligned to the clinical, operational, and economic needs of target customer cohorts.

A regional insight framework that contrasts clinical adoption models, regulatory environments, and commercial execution priorities across the Americas, EMEA, and Asia-Pacific

Regional dynamics influence clinical practice patterns, regulatory pathways, and commercial approaches across the Americas, Europe Middle East & Africa, and Asia-Pacific, producing distinct opportunity sets and execution risks for bronchoscopic biopsy device stakeholders. In the Americas, established interventional pulmonology programs and integrated cancer centers support early adoption of advanced navigation and combined diagnostic-therapeutic procedures, while private payor models and large hospital networks drive emphasis on demonstrable procedural efficiency and bundled care pathways. Procurement cycles in this region often reward evidence of comparative clinical benefit, reimbursement alignment, and robust post-market surveillance.

Across Europe, the Middle East, and Africa, market heterogeneity is pronounced: western European centers prioritize guideline-driven adoption, health-technology assessments, and centralized purchasing, whereas emerging markets in the region may emphasize cost-effective solutions and partnerships that facilitate local training. Regulatory nuances and reimbursement fragmentation necessitate adaptive go-to-market strategies that balance clinical evidence generation with pragmatic distribution models. In the Asia-Pacific region, rapid expansion of cancer care infrastructure, rising access to advanced imaging, and pronounced interest in minimally invasive diagnostics accelerate demand for navigation-enabled platforms, yet suppliers must navigate diverse regulatory environments, variable procurement frameworks, and a spectrum of hospital capabilities. Collectively, these regional insights underscore the importance of tailored market entry plans, nuanced value propositions, and investment in clinician education to support sustainable uptake across geographies.

A competitive intelligence overview highlighting how incumbents, specialized innovators, and strategic partnerships are shaping product differentiation, clinical validation, and commercialization

Competitive dynamics across bronchoscopic biopsy devices are driven by a combination of legacy endoscopy manufacturers, specialized navigation providers, and ambitious medical technology startups that bring focused innovations in imaging, software, and consumable design. Incumbent firms typically leverage established clinical relationships, global service networks, and broad product portfolios to offer integrated solutions that address procedure efficiency and lifecycle support. Newer entrants and niche players often compete on the basis of targeted performance advantages-such as enhanced peripheral reach, streamlined user interfaces, or lower-cost disposables-that can displace legacy workflows in specialized programs.

Partnerships and distribution alliances are common strategic levers, particularly when firms seek rapid access to new geographies or complementary technology stacks. Licensing arrangements for navigation software, co-development partnerships with imaging providers, and joint training programs with academic centers are frequent pathways to accelerate clinical validation and adoption. Additionally, as hospitals and ambulatory centers increasingly evaluate total cost of ownership, companies that offer bundled service contracts, outcome-focused value propositions, and flexible financing will often find greater receptivity. For investors and corporate strategists, the competitive picture suggests an environment where product differentiation, evidence generation, and scalable commercial infrastructure determine the leaders of the next adoption cycle.

Actionable strategic recommendations for commercial, clinical, and supply chain leaders to accelerate adoption, secure value-based contracting, and reduce operational exposure

Industry leaders must pursue a balanced strategy that combines clinical evidence generation, supply chain resilience, and stakeholder-aligned commercial models to secure sustained adoption of bronchoscopic biopsy devices. First, prioritize prospective clinical studies and real-world evidence initiatives that demonstrate comparative safety and diagnostic performance across key applications such as mediastinal staging and peripheral lesion sampling; evidence tailored to reimbursement stakeholders will accelerate conversion in budget-constrained environments. Second, enhance supply chain flexibility through supplier diversification, regional assembly options, and inventory optimization to mitigate tariff and geopolitical exposure while preserving competitive pricing and service responsiveness.

Third, invest in comprehensive clinician training and credentialing programs that reduce procedural variability and increase repeatable outcomes; immersive simulation, proctoring networks, and integrated digital training tools can shorten the learning curve and increase institutional confidence. Fourth, design commercial bundles that reflect end-user economics-combining device hardware, consumables, software support, and outcome-linked service agreements-to align incentives with hospital and ambulatory center priorities. Finally, pursue selective partnerships with imaging providers, pathology networks, and IT integrators to create seamless clinical workflows that demonstrate measurable improvements in patient throughput, diagnostic timelines, and multidisciplinary decision-making. Executed together, these recommendations will position organizations to capture demand responsibly while reinforcing clinical value and operational scalability.

A transparent methodology blending clinician interviews, supplier consultations, literature review, and supply chain mapping to triangulate insights and validate practical applicability

The research methodology underpinning this analysis blended primary engagement with clinical and commercial stakeholders, systematic review of regulatory and clinical literature, and qualitative supply chain mapping to ensure a holistic understanding of the bronchoscopic biopsy device ecosystem. Primary inputs included in-depth interviews with interventional pulmonologists, thoracic surgeons, hospital procurement leaders, and biomedical engineering specialists, which illuminated real-world procedural workflows, device preferences, and training needs. These conversations were complemented by consultations with device developers and distribution partners to capture product roadmaps, commercialization challenges, and manufacturing considerations.

Secondary analysis incorporated peer-reviewed clinical studies, regulatory filings, procedural guidelines, and relevant industry reports to contextualize device performance, safety profiles, and adoption drivers. Supply chain and tariff impacts were assessed through import-export data, customs classifications, and documented corporate responses to trade measures, enabling scenario-based interpretation of operational risks. Throughout, findings were triangulated to validate themes and ensure consistency across data sources, with particular attention to clinical credibility and applicability for decision-makers in manufacturing, hospital leadership, and investment communities.

A concise conclusion synthesizing how clinical innovation, operational resilience, and evidence-driven commercialization collectively determine long-term value capture in bronchoscopic biopsy devices

In sum, bronchoscopic biopsy devices are converging toward greater clinical precision, procedural decentralization, and integrated data-enabled workflows that collectively expand their role in modern thoracic care. Technology differentiation-whether through navigation fidelity, ultrathin device engineering, or multi-channel versatility-will continue to determine clinical fit across central, mediastinal, and peripheral indications. Meanwhile, commercial success will hinge on credible clinical evidence, adaptable supply chains that withstand tariff and trade volatility, and commercial models that reflect the economics of diverse end users from ambulatory centers to large hospital systems.

As stakeholders prepare for the next phase of adoption, they should align product development with real-world procedural needs, invest in clinician competency programs, and pursue partnerships that enhance the end-to-end care pathway. Organizations that proactively address evidence generation, operational resilience, and customer-centric commercialization will be best positioned to capture long-term clinical and commercial value in this evolving landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bronchoscopic Biopsy Devices Market, by Technology

  • 8.1. Convex Probe EBUS
  • 8.2. Electromagnetic Navigation
  • 8.3. Radial EBUS

9. Bronchoscopic Biopsy Devices Market, by Product Type

  • 9.1. Double Channel Devices
  • 9.2. Single Channel Devices
  • 9.3. Ultrathin Devices

10. Bronchoscopic Biopsy Devices Market, by Procedure Type

  • 10.1. Diagnostic Biopsy
  • 10.2. Therapeutic Intervention

11. Bronchoscopic Biopsy Devices Market, by Application

  • 11.1. Central Lesion Diagnosis
  • 11.2. Mediastinal Staging
    • 11.2.1. Conventional Tbna
    • 11.2.2. Ebus Guided Tbna
  • 11.3. Peripheral Lesion Diagnosis
    • 11.3.1. Direct Sampling Without Navigation
    • 11.3.2. Electromagnetic Navigated Sampling
    • 11.3.3. Virtual Bronchoscopy Navigation

12. Bronchoscopic Biopsy Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
    • 12.1.1. Corporate Owned
    • 12.1.2. Physician Owned
  • 12.2. Hospital Operating Rooms
    • 12.2.1. Private Hospitals
    • 12.2.2. Public Hospitals
  • 12.3. Specialized Cancer Centers

13. Bronchoscopic Biopsy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bronchoscopic Biopsy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bronchoscopic Biopsy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Bronchoscopic Biopsy Devices Market

17. China Bronchoscopic Biopsy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Ambu A/S
  • 18.6. Becton, Dickinson, and Company
  • 18.7. Body Vision Medical Inc.
  • 18.8. Boston Scientific Corporation
  • 18.9. CONMED Corporation
  • 18.10. Cook Group Incorporated
  • 18.11. Erbe Elektromedizin GmbH
  • 18.12. FUJIFILM Holdings Corporation
  • 18.13. Johnson & Johnson Services, Inc.
  • 18.14. KARL STORZ SE & Co. KG
  • 18.15. Medi-Globe GmbH
  • 18.16. Medtronic PLC
  • 18.17. Merit Medical Systems, Inc.
  • 18.18. Micro-Tech (Nanjing) Co., Ltd
  • 18.19. Olympus Corporation
  • 18.20. Richard Wolf GmbH
  • 18.21. Shanghai Aohua Photoelectricity Endoscope Co.,Ltd.
  • 18.22. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 202. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 208. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 209. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 211. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 212. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 218. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 219. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)